Aclaris Therapeutics, Inc. (ACRS) › Shares OutstandingAclaris Therapeutics, Inc. (ACRS) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2014: 2.73M2015: 20.16M2016: 26.06M2017: 30.86M2018: 41.21M2019: 41.49M2020: 45.11M2021: 61.23M2022: 66.69M2023: 70.89M2024: 107.85M2025: 120.50M120.50M2014Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY2025120.50M+11.7%2024107.85M+52.1%202370.89M+6.3%202266.69M+8.9%202161.23M+35.7%202045.11M+8.7%201941.49M+0.7%201841.21M+33.6%201730.86M+18.4%201626.06M+29.3%201520.16M+638.3%20142.73M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share